WAVE Life Sciences Ltd (NASDAQ:WVE)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - WVE
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - WVE
- Market Cap$486.310m
- SymbolNASDAQ:WVE
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINSG9999014716
Company Profile
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.WAVE Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.
Latest WVE news
Currently there for this company. Visit our news hub for other news .